“Ultimately, the hope is to find other avenues to reduce the risk for depression and depression symptoms,” says Vaughn McCall, MD.
“I was so excited because I've had all of these leadership opportunities over the last four years; I just feel like this honors all that work," says Ana-Sophia Chung.
"Identifying these populations may allow us to unveil populations that correlate with disease stage, tumor burden and therapy potential," says Austin Lowery.
“This lab is where the next generation of otolaryngologists will learn the anatomy that defines our specialty,” says Stil E. Kountakis, MD, PhD.
“A good thing about this is, because this is an FDA-approved drug, it's ready to be tested in Alzheimer’s patients,” says Qin Wang, MD, PhD.
"These discoveries place Augusta University and the Immunology Center of Georgia at the forefront of modern immunology," says Klaus Ley, MD.
